PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-438.75%
Both yoy net incomes decline, with CNQ at -39.49%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
-11.24%
Negative yoy D&A while CNQ is 0.32%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
147.62%
Well above CNQ's 60.87% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
154.17%
SBC growth well above CNQ's 273.17%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-21400.00%
Both reduce yoy usage, with CNQ at -292.57%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-100.00%
AR is negative yoy while CNQ is 0.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-21400.00%
Negative yoy usage while CNQ is 0.00%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-101.55%
Negative yoy while CNQ is 125.77%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-52.86%
Both yoy CFO lines are negative, with CNQ at -27.86%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
8.33%
CapEx growth well above CNQ's 2.61%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
-93.52%
Negative yoy acquisition while CNQ stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
2206.45%
Purchases growth of 2206.45% while CNQ is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-80.38%
We reduce yoy sales while CNQ is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
10.70%
Less 'other investing' outflow yoy vs. CNQ's 80.00%. David Dodd would see a stronger short-term cash position unless competitor invests more wisely.
-178.01%
We reduce yoy invests while CNQ stands at 7.15%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
33.33%
We repay more while CNQ is negative at -221.77%. John Neff notes advantage in lowering leverage if competitor is ramping up debt or repaying less.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.